Turn Options Into Opportunities
Products and Services for pharmaceutical development and manufacturing
Interphex 2025
Come meet us at Interphex 2025 booth #2841 and explore our options to intensify and optimize your process.
- Process Analytical Technology (PAT)
Learn how PAT improves process understanding and supports automated control strategies to help reduce contamination risks and batch failures.
- Seed train and perfusion technologies
Whether focusing on intensified fed-batch or perfusion processes, discover our integrated solutions designed to boost volumetric productivity, compress timelines, and reduce manufacturing and capital expenses.
- Fluid management solutions
Explore the latest scalable single-use solutions for fluid management, from media preparation to final filling, that offer enhanced flexibility while minimizing process risks. Discover how Ultimus® film increases durability for challenging applications while ensuring ease of handling and flexibility.
- Downstream bioprocessing systems and technologies
Discuss with our technical team how we can help you choose the best strategy to realize the benefits of downstream process intensification and optimization.
- Single-use final filtration assemblies
Explore how single-use final filtration systems enhance flexibility and productivity to meet the demands of manufacturing a variety of drug products and fill volumes while maximizing product recovery and operator safety.
Attend our Talks:
Tuesday, April 1
11:30 am-12:00 pm
Location: Technical Theater & Workshop – Stage 4
What do you need to do to qualify a single-use assembly?
Presenter: Jessica Shea, Senior Program Manager
Single-use technology (SUT) is well established in all stages of bioprocess manufacturing, including upstream, downstream, and fill/finish unit operations. The implementation of SUT usually starts with development of the user requirement specification (URS). The end users at biopharmaceutical companies work closely with the supplier to select components and assemblies (standard or custom) to meet the application requirements. Single-use qualification and regulatory considerations can include properties such as physical, functional, biological, chemical and sterilization.
Wednesday, April 2
11:30 am-12:00 pm
Location: Technical Theater & Workshop – Stage 4
Integrating continuous capture and inline viral inactivation technologies
Presenter: Kristen Cotoni, Research Scientist
Fully continuous downstream process is enabled by an inline Virus Inactivation (iVI) system which controls pH and residence time distribution using coiled flow incubation chambers. Continuous connected capture integrating multicolumn chromatography with iVI delivered high product yield and quality.
3:00 to 3:45 PM
Location: Stage 2, Ensuring Access to Innovative Medicines
Business continuity in biopharmaceutical supply chains during COVID-19
Presenter: Sarah LeChat, Global Strategic Marketing Manager
The presentation will highlight the critical role of business continuity management (BCM) in ensuring the uninterrupted supply of Benzonase® endonuclease during the COVID-19
pandemic. With demand for this essential enzyme surging, established BCM (Business Continuity Management) processes, based on ISO Standard 22301, facilitated effective risk identification, assessment, and mitigation strategies. Key components of the BCM planning, including annual prioritization, disaster recovery planning, and the establishment of backup manufacturing capabilities, will be discussed. Insights gained from the pandemic have driven continuous improvements in supply chain resilience, crisis management, and operational flexibility. Proactive measures taken ensured the consistent availability of Benzonase® endonuclease, supporting the production of over two billion vaccine doses and positioning the organization to effectively address future challenges in the biopharmaceutical landscape.
3:00 to 3:45 PM
Location: Stage 3, Late Breaking
Operational method to improve sustainability in single-use bioprocessing
Presenter: Marisa Maher, Applications Engineer
The transition towards a circular economy in the plastic industry emphasizes sustainable practices for single-use products in biomanufacturing. Traditional single-use technologies provide lower ecological footprints and reduced cross-contamination risks compared to stainless steel, yet there is a need for enhanced manufacturing efficiency and cost reduction. Incorporating circularity at the point of use, through methods like continuous processing and re-use of single-use assemblies, can improve operational efficiency and minimize waste. A newly designed bioprocessing film exhibits 2.85x greater tensile strength, 10x abrasion resistance, and 2x puncture resistance than average commercially available films, ensuring integrity during multiple cycles and reducing leak risks. Studies using this film in a "multiple fill and drain" application demonstrate its potential to decrease consumable waste and replacement frequency, while also providing economic benefits by lowering material costs and waste management expenses, thus supporting environmental sustainability.
Register Now:
Interphex 2025
April 1-3, 2025
Jacob Javits Convention Center
Booth 2841
To continue reading please sign in or create an account.
Don't Have An Account?